HDAC inhibitors have been used in a variety of animal models of diseases such as Huntington’s disease, amyotrophic lateral sclerosis (ALS), and spinal and bulbar muscular atrophy (SBMA) [35,36,37,38,39,40,41]. This evidence concerns the gene HDAC9 and amyotrophic lateral sclerosis.